362 related articles for article (PubMed ID: 28826799)
1. High-sensitivity C-reactive protein and long term reperfusion success of primary percutaneous intervention in ST-elevation myocardial infarction.
Groot HE; Karper JC; Lipsic E; van Veldhuisen DJ; van der Horst ICC; van der Harst P
Int J Cardiol; 2017 Dec; 248():51-56. PubMed ID: 28826799
[TBL] [Abstract][Full Text] [Related]
2. Relation of inflammatory markers with myocardial and microvascular injury in patients with reperfused ST-elevation myocardial infarction.
Reindl M; Reinstadler SJ; Feistritzer HJ; Klug G; Tiller C; Mair J; Mayr A; Jaschke W; Metzler B
Eur Heart J Acute Cardiovasc Care; 2017 Oct; 6(7):640-649. PubMed ID: 27440935
[TBL] [Abstract][Full Text] [Related]
3. Multimarker approach for the prediction of microvascular obstruction after acute ST-segment elevation myocardial infarction: a prospective, observational study.
Feistritzer HJ; Reinstadler SJ; Klug G; Reindl M; Wöhrer S; Brenner C; Mayr A; Mair J; Metzler B
BMC Cardiovasc Disord; 2016 Nov; 16(1):239. PubMed ID: 27894261
[TBL] [Abstract][Full Text] [Related]
4. High Serum Secreted Frizzled-Related Protein 5 Levels Associates with Early Improvement of Cardiac Function Following ST-Segment Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention.
Du Y; Zhao Y; Zhu Y; Hu C; Zhang J; Ji Q; Liu W; Han H; Yang L; Zhang D; Tong S; Wang Z; Guo Y; Liu X; Zhou Y
J Atheroscler Thromb; 2019 Oct; 26(10):868-878. PubMed ID: 30773518
[TBL] [Abstract][Full Text] [Related]
5. Endothelial function after ST-elevation myocardial infarction in patients with high levels of high-sensitivity CRP and Lp-PLA
Kandhai-Ragunath JJ; de Wagenaar B; Doelman C; van Es J; Jørstad HT; Peters RJG; Doggen CJM; von Birgelen C
Cardiovasc Revasc Med; 2017; 18(3):202-206. PubMed ID: 28110894
[TBL] [Abstract][Full Text] [Related]
6. Pentraxin 3 in primary percutaneous coronary intervention for ST elevation myocardial infarction is associated with early irreversible myocardial damage : Kinetic profile, relationship to interleukin 6 and infarct size.
Butt N; Bache-Mathiesen LK; Ushakova A; Nordrehaug JE; Jensen SE; Munk PS; Danchin N; Dubois-Rande JL; Hansen HS; Paganelli F; Corvoisier PL; Firat H; Erlinge D; Atar D; Larsen AI
Eur Heart J Acute Cardiovasc Care; 2020 Jun; 9(4):302-312. PubMed ID: 32403934
[TBL] [Abstract][Full Text] [Related]
7. Plasma apelin-12 levels may predict in-hospital major adverse cardiac events in ST-elevation myocardial infarction and the relationship between apelin-12 and the neutrophil/lymphocyte ratio in patients undergoing primary coronary intervention.
Topuz M; Oz F; Akkus O; Sen O; Topuz AN; Bulut A; Ozbicer S; Okar S; Koc M; Gur M
Perfusion; 2017 Apr; 32(3):206-213. PubMed ID: 27770057
[TBL] [Abstract][Full Text] [Related]
8. An hs-TNT Second Peak Associated with High CRP at Day 2 Appears as Potential Biomarkers of Micro-Vascular Occlusion on Magnetic Resonance Imaging after Reperfused ST-Segment Elevation Myocardial Infarction.
Huet F; Akodad M; Kuster N; Kovacsik H; Leclercq F; Dupuy AM; Gervasoni R; Khoury G; Macia JC; Cristol JP; Roubille F
Cardiology; 2018; 140(4):227-236. PubMed ID: 30138917
[TBL] [Abstract][Full Text] [Related]
9. Impact of multivessel coronary artery disease on reperfusion success in patients with ST-elevation myocardial infarction: A substudy of the AIDA STEMI trial.
de Waha S; Eitel I; Desch S; Fuernau G; Pöss J; Schuler G; Thiele H
Eur Heart J Acute Cardiovasc Care; 2017 Oct; 6(7):592-600. PubMed ID: 26691729
[TBL] [Abstract][Full Text] [Related]
10. Temporal changes in biomarkers and their relationships to reperfusion and to clinical outcomes among patients with ST segment elevation myocardial infarction.
van Diepen S; Alemayehu WG; Zheng Y; Theroux P; Newby LK; Mahaffey KW; Granger CB; Armstrong PW
J Thromb Thrombolysis; 2016 Oct; 42(3):376-85. PubMed ID: 27324144
[TBL] [Abstract][Full Text] [Related]
11. The influence of plasma 25-(OH) vitamin D levels in acute ST elevation myocardial infarction.
Şen Ö; Topuz M; Acele A; Akkuş O; Baykan AO; Koç M
Cardiol J; 2017; 24(6):677-684. PubMed ID: 28612906
[TBL] [Abstract][Full Text] [Related]
12. High sensitive C-reactive protein and the risk of acute kidney injury among ST elevation myocardial infarction patients undergoing primary percutaneous intervention.
Shacham Y; Leshem-Rubinow E; Steinvil A; Keren G; Roth A; Arbel Y
Clin Exp Nephrol; 2015 Oct; 19(5):838-43. PubMed ID: 25492251
[TBL] [Abstract][Full Text] [Related]
13. Fibroblast growth factor 23 as novel biomarker for early risk stratification after ST-elevation myocardial infarction.
Reindl M; Reinstadler SJ; Feistritzer HJ; Mueller L; Koch C; Mayr A; Theurl M; Kirchmair R; Klug G; Metzler B
Heart; 2017 Jun; 103(11):856-862. PubMed ID: 27979879
[TBL] [Abstract][Full Text] [Related]
14. The impact of admission red cell distribution width on long-term cardiovascular events after primary percutaneous intervention: A four-year prospective study.
Isik T; Kurt M; Tanboga IH; Ayhan E; Gunaydin ZY; Kaya A; Uyarel H
Cardiol J; 2016; 23(3):281-8. PubMed ID: 26711461
[TBL] [Abstract][Full Text] [Related]
15. Insights into the change in brain natriuretic peptide after ST-elevation myocardial infarction (STEMI): why should it be better than baseline?
Ezekowitz JA; Théroux P; Welsh R; Bata I; Webb J; Armstrong PW
Can J Physiol Pharmacol; 2007 Jan; 85(1):173-8. PubMed ID: 17487257
[TBL] [Abstract][Full Text] [Related]
16. Non-contrast cardiac CT immediately after percutaneous coronary intervention: does it predict the risk of left ventricular remodeling in patients with ST-elevation myocardial infarction?
Khurelsukh K; Kim YH; Seon HJ; Song JH; Park SY; Moon SM; Kim SH; Sim DS; Ahn Y
Int J Cardiovasc Imaging; 2016 Jun; 32 Suppl 1():147-54. PubMed ID: 27139462
[TBL] [Abstract][Full Text] [Related]
17. Circulating HtrA2 as a novel biomarker for mitochondrial induced cardiomyocyte apoptosis and ischemia-reperfusion injury in ST-segment elevation myocardial infarction.
Hortmann M; Robinson S; Mohr M; Haenel D; Mauler M; Stallmann D; Reinoehl J; Duerschmied D; Peter K; Bode C; Ahrens I
Int J Cardiol; 2017 Sep; 243():485-491. PubMed ID: 28602551
[TBL] [Abstract][Full Text] [Related]
18. High-sensitivity troponin T for prediction of left ventricular function and infarct size one year following ST-elevation myocardial infarction.
Reinstadler SJ; Feistritzer HJ; Klug G; Mair J; Tu AM; Kofler M; Henninger B; Franz WM; Metzler B
Int J Cardiol; 2016 Jan; 202():188-93. PubMed ID: 26397408
[TBL] [Abstract][Full Text] [Related]
19. NT-proBNP level before primary PCI and risk of poor myocardial reperfusion: Insight from the On-TIME II trial.
Fabris E; Ten Berg JM; Hermanides RS; Ottervanger JP; Dambrink JHE; Gosselink AM; Sinagra G; Koopmans PC; Giannitsis E; Hamm C; van 't Hof AWJ
Am Heart J; 2021 Mar; 233():78-85. PubMed ID: 33388289
[TBL] [Abstract][Full Text] [Related]
20. Implications of ventricular arrhythmia "bursts" with normal epicardial flow, myocardial blush, and ST-segment recovery in anterior ST-elevation myocardial infarction reperfusion: a biosignature of direct myocellular injury "downstream of downstream".
Majidi M; Kosinski AS; Al-Khatib SM; Smolders L; Cristea E; Lansky AJ; Stone GW; Mehran R; Gibbons RJ; Crijns HJ; Wellens HJ; Gorgels AP; Krucoff MW
Eur Heart J Acute Cardiovasc Care; 2015 Feb; 4(1):51-9. PubMed ID: 25063574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
